WHO ICTRP trial

Effect of Flumazenil Drip On Speed Of Recovery And Prevention Of Complications…

IRCT20120629010133N3 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting

Key facts

Trial ID IRCT20120629010133N3
Public title Effect of Flumazenil Drip On Speed Of Recovery And Prevention Of Complications In Severe Acute Benzodiazepine Toxicity
Scientific title Effect of Flumazenil Drip On Speed Of Recovery And Prevention Of Complications In Severe Acute Benzodiazepine Toxicity
Primary sponsor NIMAD (National Institute for Medical Research Development)
Registry Iranian Registry of Clinical Trials (IRCT)
Recruitment status Not Recruiting
Study type interventional
Phase 2-3
Countries Iran (Islamic Republic of)
Conditions Benzodiazepine poisoning. Poisoning by, adverse effect of and underdosing of hydantoin derivatives;T42.0
Interventions Intervention 1: Intervention group: Administration of flumazenil drip (initial dose of 200 micro per hour and its adjustment based on patient's situations) followed by its tapering. Intervention 2: Control group: are the patients who do not…
Registration date May 31, 2020
Target size 50
Registry page irct.behdasht.gov.ir

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations